While there was evidence of systemic inflammation indicated by elevated levels of circulating IL-6, sTNFRI and VEGF, less than 5% of the patients in the current study met the criteria for the hyper-inflammation phenotype described in ARDS [34] and had levels of circulating mediators lower than described in “usual” sepsis [13]. The gene discussed is IL6; the disease is acute respiratory distress syndrome.